0001179110-14-009845.txt : 20140624 0001179110-14-009845.hdr.sgml : 20140624 20140605170233 ACCESSION NUMBER: 0001179110-14-009845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140604 FILED AS OF DATE: 20140605 DATE AS OF CHANGE: 20140605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIPTON KAREN SHOOS CENTRAL INDEX KEY: 0001255681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 14894295 MAIL ADDRESS: STREET 1: 8101 GLENBROOK ROAD CITY: BETHESDA STATE: MD ZIP: 20814 4 1 edgar.xml FORM 4 - X0306 4 2014-06-04 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001255681 LIPTON KAREN SHOOS C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 1 0 0 0 Common Stock 2014-06-04 4 A 0 2000 A 15333 D Non-Qualified Stock Option (right to buy) 13.45 2014-06-04 4 A 0 2000 0 A 2024-06-04 Common Stock 2000 2000 D On June 4, 2014, the Company awarded 2,000 shares of the Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option and Incentive Plan, subject to time-based forfeiture restrictions. Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Such option vests in four equal quarterly installments beginning September 4, 2014. /s/ Avery W. Catlin, attorney in fact for Karen L. Shoos 2014-06-05